Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.60 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 4/20 | 0.42 |
| ▸ | ADRA2B | P18089 | 4/20 | 0.42 |
| ▸ | ADRA2C | P18825 | 4/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 4/20 | 0.42 |
| ▸ | ADRA1D | P25100 | 3/20 | 0.42 |
| ▸ | ADRA1B | P35368 | 3/20 | 0.42 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
| ▸ | ACP3 | P15309 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5609722 | 0.81 | ALDH1A1 (0.56) | ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6 | |
| SCHEMBL5610036 | 0.81 | ALDH1A1 (0.56) | ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6 | |
| SCHEMBL129525 | 0.81 | ALDH1A1 (0.56) | ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6 | |
| SCHEMBL664990 | 0.81 | ALDH1A1 (0.56) | ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6 | |
| SCHEMBL5609476 | 0.81 | ALDH1A1 (0.56) | ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6 | |
| SCHEMBL6750375 | 0.81 | ALDH1A1 (0.56) | ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6 | |
| SCHEMBL666055 | 0.81 | ALDH1A1 (0.56) | ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6 | |
| SCHEMBL11631619 | 0.80 | ALDH1A1 (0.60) | ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6 | |
| SCHEMBL2494544 | 0.79 | ALDH1A1 (0.65) | ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6 | |
| SCHEMBL2151890 | 0.78 | ALDH1A1 (0.52) | ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1388540-B1 | ACRYLIC ESTERS AND USE THEREOF | MITSUI CHEMICALS INC (JP) | 2007-09-05 | — | — | EP | disclosed |
| US-6835844-B2 | Acrylic esters and use thereof | MITSUI CHEMICALS, INC. (JP) | 2004-12-28 | — | — | US | disclosed |
| US-20040102592-A1 | Acrylic esters and use thereof | MITSUI CHEMICALS, INC. (JP) | 2004-05-27 | — | — | US | disclosed |
| EP-1388540-A1 | ACRYLIC ESTERS AND USE THEREOF | Mitsui Chemicals, Inc. (JP) | 2004-02-11 | — | — | EP | disclosed |
| US-5691319-A | ANTICARCINOGENIC AGENTS | SANKYO COMPANY, LIMITED (JP) | 1997-11-25 | — | — | US | disclosed |
| EP-0536936-B1 | Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use | SANKYO CO (JP) | 1996-08-14 | — | — | EP | disclosed |
| EP-0536936-A1 | Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use | Sankyo Company Limited (JP) | 1993-04-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040102592-A1 | Acrylic esters and use thereof | RPS4Y1, EPB41, RPS4X | ALDH1A1 848/4885CYP1A2 618/4885CYP2C9 919/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.